Complera® is an anti-HIV medication that contains an older high-dose version of tenofovir (TDF) that is linked to a higher risk of bone injuries, tooth decay, osteroporosis, and kidney damage.
What You Can Do & How We Can Help
The Schmidt Firm, PLLC is currently accepting Complera induced injury cases in all 50 states. If you or somebody you know has been injured by severe side effects of Complera in the kidneys, bones, or teeth, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
What is Complera?
Complera® combines the anti-HIV medications Truvada® (emtricitabine and tenofovir disoproxil fumarate or TDF) with Edurant® (rilpivirine) for a complete, 1-pill, once-a-day HIV-1 treatment.
Complera Safety Risks
Complera contains an older high-dose version of tenofovir (TDF). Unfortunately, it has been linked to a higher risk of severe kidney damage, dental problems, and bone mineral loss compared to a newer lower-dose version of tenofovir — tenofovir alafenamide fumarate, or TAF.
Kidney Injuries Linked to Complera
- Chronic kidney disease
- Declining kidney function
- Acute kidney injury
- Acute renal failure
- Fanconi syndrome
- Kidney failure
Bone Injuries Linked to Complera
- Osteoporosis
- Decreased bone mineral density
- Osteopenia
- Bone fractures
- Dental problems
- Tooth decay
- Tooth loss
HIV Drug Lawsuits
In May 2018, a lawsuit was filed by 2 men who accuse Gilead of intentionally delaying development of TAF (a safer version of tenofovir) to maximize profits on their HIV drugs with an older version of tenofovir that had a higher risk of bone and kidney side effects.
Instead of continuing to develop the safer alternative, the lawsuit claims, the Foster City company decided to hide tenofovir’s risks while earning billions of dollars as it became one of the world’s most prescribed medicines for HIV.
Gilead is now urging doctors to switch their patients to the newer drugs to reduce possible harm to their kidneys and bones.
What is the Problem?
Lawsuits claim that HIV patients suffered for years of “additional accumulated kidney and bone toxicity” while using Complera and other HIV medications with the older version of tenofovir.
Who Filed the Lawsuit?
The lawsuit was filed by Michael Lujano, a man from Los Angeles who was diagnosed with bone loss and osteoporosis of the spine, neck and hip. The other plaintiff is Jonathan C. Gary, a man from San Diego who was diagnosed with Fanconi syndrome, a rare kidney disorder. In 2017, he was diagnosed with osteopenia and osteoporosis at age 59.
Do I have a Complera Lawsuit?
The Schmidt Firm, PLLC is currently accepting Complera induced injury cases in all 50 states. If you or somebody you know has been injured by severe side effects of Complera in the kidneys, bones, or teeth, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.